MedPal AI (LSE:MPAL) ROE % Adjusted to Book Value: -15.72% (As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is MedPal AI ROE % Adjusted to Book Value?

MedPal AI LSE:MPAL ROE % Adjusted to Book Value is -15.72% as of Feb. 2026. The stock has 1 warning sign investors should review.

MedPal AI's ROE % for the quarter that ended in Feb. 2026 was -687.82%. MedPal AI's PB Ratio for the quarter that ended in Feb. 2026 was 43.75. MedPal AI's ROE % Adjusted to Book Value for the quarter that ended in Feb. 2026 was -15.72%.

MedPal AI ROE % Adjusted to Book Value Related Terms

MedPal AI ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for MedPal AI's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedPal AI ROE % Adjusted to Book Value Chart

MedPal AI Annual Data
Trend Aug22 Aug23 Aug24 Aug25
ROE % Adjusted to Book Value
0.00 0.00 0.00 -24.05

MedPal AI Semi-Annual Data
Aug22 Aug23 Feb24 Aug24 Feb25 Aug25 Feb26
ROE % Adjusted to Book Value Get a 7-Day Free Trial 0.00 0.00 0.00 -22.79 -15.72

LSE:MPAL vs VEEV, BTSG, HQY: ROE % Adjusted to Book Value Comparison

For the Health Information Services subindustry, MedPal AI's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MedPal AI ROE % Adjusted to Book Value vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MedPal AI's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where MedPal AI's ROE % Adjusted to Book Value falls into.


MedPal AI ROE % Adjusted to Book Value Calculation

MedPal AI's ROE % Adjusted to Book Value for the fiscal year that ended in Aug. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-581.26% / 24.17
=-24.05%

MedPal AI's ROE % Adjusted to Book Value for the quarter that ended in Feb. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-687.82% / 43.75
=-15.72%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -15.72% mean?
MedPal AI (LSE:MPAL) has a ROE % Adjusted to Book Value of -15.72% as of Feb. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on MedPal AI and its competitors.
Is MedPal AI's ROE % Adjusted to Book Value too high?
MedPal AI's current ROE % Adjusted to Book Value is -15.72%.
How does MedPal AI's ROE % Adjusted to Book Value compare to VEEV and BTSG?
MedPal AI's ROE % Adjusted to Book Value of -15.72% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Healthcare Providers & Services company?
A good ROE % Adjusted to Book Value depends on the Healthcare Providers & Services industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on MedPal AI and its competitors. MedPal AI's current ROE % Adjusted to Book Value is -15.72%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedPal AI stock overvalued right now?
MedPal AI (LSE:MPAL) has a current ROE % Adjusted to Book Value of -15.72%. The current ROE % Adjusted to Book Value is -15.72%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For MedPal AI (LSE:MPAL), the current ROE % Adjusted to Book Value is -15.72% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MedPal AI Business Description

Other Exchanges Z1N:Germany
Address 71 Queen Victoria Street, Floor 8, London, GBR, EC4V 4AY
MedPal AI PLC is a UK-based digital health and artificial intelligence company focused on the development and commercialisation of AI-enabled healthcare platforms.. Its platform aggregates data across devices and apps (including Apple Health, Fitbit, Garmin, and Google Fit) to deliver real-time, personalized health insights. The Company has two reportable segments, Software and Corporate.